Publications
Specialty
Search
Oncology
09/30/2024
In the TROPION-PanTumor03 study, what was the confirmed objective response rate among patients with endometrial cancer treated with datopotamab deruxtecan?
Oncology
09/30/2024
According to results from a univariable and multivariable analysis, does lymph node dissection at the time of hysterectomy improve overall survival among patients with stage 3 endometrial cancer?
First Report Managed Care
09/30/2024
As labor shortages continue to plague the health care industry, providers are turning to artificial intelligence tools to streamline administrative tasks, enhance patient care, and improve staff satisfaction, offering a glimpse into the future of health care operations.
Today's Wound Clinic, Wound Care
09/30/2024
NPWT continues to play a significant role in wound/ulcer management protocols throughout the continuum of care. However, confusion reigns regarding who Medicare will separately pay to provide and apply the equipment and supplies. This article should clear up some of the confusion.
EP Lab Digest
09/30/2024
Medtronic Press Release
Psych Congress NP Institute, Psychiatry & Behavioral Health
09/30/2024
Learn how this critical neurotransmitter is reshaping our understanding of depression, cognition, and mood disorders.
EMSWorld
09/30/2024
Navigating the complex landscape of ambulance fleet management can be challenging, especially in the face of rising costs and supply chain disruptions. How can EMS agencies optimize their fleet performance while maintaining efficiency and cost-effectiveness?
On this episode of EMS World Podcasts, host Mike McCabe sits down with Kyle Wells, assistant chief of EMS for AtlantiCare, to delve into these critical issues. Together, they explore key obstacles and discuss strategies for implementing a standardized approach to improve fleet performance.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
09/30/2024
“Lifetime management of aortic stenosis calls for leaflet modification solutions like ShortCut™ to ensure that we are carefully addressing the risk of coronary obstruction before implanting a valve,” said Martin B. Leon, MD.
Advances in Inflammatory Bowel Disease Network
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
Podiatry Today
09/29/2024
A closer look at a recent study in the Journal of Rheumatology.
Oncology
09/27/2024
Based on results from the phase 3 LIBRETTO-531 study, the FDA has granted traditional approval to selpercatinib for adult and pediatric patients 2 years and older with advanced or metastatic medullary thyroid cancer harboring a RET mutation.
First Report Managed Care
09/27/2024
Harvard Medical School researchers unveil a potentially groundbreaking AI tool, TxGNN, that identifies potential drug candidates for 17 080 diseases, offering hope for patients with rare and neglected conditions.
First Report Managed Care
09/27/2024
A study published in the Annals of Clinical Microbiology and Antimicrobials explores the impact of multidrug-resistant (MDR) bacterial infections on the clinical outcomes of adult patients with bronchiectasis, finding a significant increase in in-hospital and 3-year mortality rates compared to non-MDR infected patients.
Pharmacy Learning Network
09/27/2024
Former pharmacist Robert Courtney, who was sentenced for diluting prescription medications, was granted early release despite protests from victims and lawmakers.
Wounds
09/27/2024
Industry-leading ‘Wounds’ journal will publish 200+ abstracts accepted for the four-day meeting, set for October 2-5 in Las Vegas
Psych Congress Network, Psychiatry & Behavioral Health
09/27/2024
The US Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults.
EP Lab Digest
09/27/2024
Heart Rhythm Society Press Release
First Report Managed Care
09/27/2024
Learn from a guest expert appointed to the FDA's Digital Health Advisory Committee about shaping the regulatory framework for digital health technologies.
EP Lab Digest
09/27/2024
Boston Scientific Press Release
MARLBOROUGH, Mass., Sept. 27, 2024 -- Boston Scientific Corporation (NYSE: BSX) announced it has received Pharmaceuticals and Medical Device Agency (PMDA) approval in Japan for the FARAPULSE™ Pulsed Field Ablation (PFA) System. The FARAPULSE PFA System, which is indicated for the isolation of pulmonary veins in the treatment of paroxysmal atrial fibrillation (AF), is a novel alternative to standard-of-care thermal ablation treatment.
Journal of Clinical Pathways
09/27/2024
Yating Wang, MD, shares the findings and future implications of her study on survival trends among patients with metastatic non–small cell lung cancer (NSCLC) before and after the approval of immunotherapy in the US.
Reimbursement Library From A to Z
Subscribe and never miss an article!
Today's Wound Clinic Newsletter
